Department of Microbiology and Molecular
Genetics, Harvard Medical School, Boston, Massachusetts 02115
 |
INTRODUCTION |
In the natural environment,
chemoorganotrophs such as Escherichia coli obtain both their
carbon and energy from organic matter released by other cells. The
mechanisms of organic nutrient release are variable, ranging from
regulated extrusion of metabolic end products to release as a result of
death and lysis of donor cells (3, 21-23, 34). However, the
actual bioavailability of carbon in nature is low due to intense
competition (22, 23). As a result, natural microbial
populations spend the majority of their lives under starvation stress,
interspersed with sporadic and short-lived periods of growth as
nutrients become available.
Our laboratory uses carbon-starved cultures of E. coli as an
experimental model to understand the processes of survival and evolution in natural microbial populations. E. coli can
survive extended periods of starvation. In aerated rich medium
(Luria-Bertani [LB] broth), E. coli ceases growth due to
carbon limitation (37). During the first several days of
starvation, the population loses 90 to 99% of the viable counts
(40). However, the viable counts nearly level off after
these first few days, and populations can survive for several years in
this spent LB medium aerated at 37°C without further addition of
carbon (7, 8). As the cultures consume exogenous carbon
during exponential growth, the biomass is the most likely source of
carbon during extended survival, which becomes available when the cells die.
While the overall population of stationary-phase E. coli
cultures may be considered starved in that there is no net increase in
biomass, there are subpopulations that are clearly not starved, as they
are able to grow as a subculture and take over the population (8,
38-40). These subpopulations consist of mutants with enhanced fitness during starvation. The ability to grow during starvation has
been termed the growth advantage in stationary phase (GASP) phenotype
(38). Studies on cultures starved for extended periods demonstrate that the GASP phenomenon is continuous: multiple rounds of
population takeovers occur throughout the starvation period (7,
40). Interestingly, as the cultures age, they increase in
diversity, as several genetically distinct subpopulations coexist (7).
The first mutation conferring the GASP phenotype after growth in rich
media was identified as an allele of rpoS (40), a gene whose product,
S, is responsible for the regulation
of many genes during starvation stress (12). Transduction of
the GASP allele of rpoS (rpoS819) into an
otherwise wild-type strain was sufficient to confer the GASP phenotype
(40). The rpoS819 allele is a 46-bp duplication at the 3' end of the gene, which results in a replacement of the last
four residues in
S with 39 new amino acids. Expression
of two
S-dependent genes, katE
(25) and bolA (4, 15), are both reduced in the rpoS819 strain (40), indicating a
reduction of function in this allele. The physiological basis for the
fitness gain of the rpoS819 mutation is not yet known.
The purpose of our investigation was to understand how GASP mutations
alter cell physiology to provide fitness gains in stationary phase. To
this end, we sought to identify and characterize new GASP mutations.
ZK1141, an isolate from an aged culture of the rpoS819
strain, was capable of outcompeting its rpoS819 parent, indicating that additional GASP mutations accumulated in this strain
(38). In this study, we have demonstrated that the ZK1141 strain has acquired three new GASP mutations, each of which can confer
the GASP phenotype on the rpoS819 parent. Each of these newly identified GASP alleles, as well as the rpoS819
allele, increased starvation survival fitness in an additive manner.
Each of these four GASP alleles also conferred growth advantages on amino acids as the sole sources of carbon and energy. Similar to the
competitive fitnesses, these growth phenotypes were additive.
 |
MATERIALS AND METHODS |
Bacterial strains.
The E. coli strains used in
this study are listed in Table 1.
Media and growth conditions.
All experiments were performed
at 37°C, except where noted. The media used in this study have been
previously described (19). M63 minimal medium was
supplemented with 1 µg of thiamine per ml and 1 mM MgSO4.
All amino acids used in this study were of the L
configuration. Where appropriate, LB plates were supplemented with
streptomycin (25 µg/ml), nalidixic acid (20 µg/ml), tetracycline (15 µg/ml), kanamycin (50 µg/ml), or chloramphenicol (30 µg/ml). All chemicals were from Sigma. Optical density (OD) was monitored with
a Spectronic 20D+ Spectrophotometer (Milton Roy).
Genetic techniques.
Phage P1vir transduction and
Hfr conjugation using the Singer et al. (31) strain
collections were performed as described elsewhere (19).
Insertional mutagenesis with mini-Tn10 transposons from the
vectors
NK1323 (Tcr),
NK1316 (Kanr), and
NK1324 (Cmr) was performed as described previously
(13).
Construction of GASP strains.
Because incorporation of new
genetic markers can alter the fitness of bacteria, we constructed our
strains such that the final strains differed from the parental strains
only by the allele(s) of the GASP loci. This was achieved by first
bringing an auxotrophy mutation or the streptomycin-sensitive
(Sms) allele of rpsL that mapped near the GASP
loci (see Results) into the recipient by P1vir transduction.
We could then cotransduce the GASP alleles with P1vir grown
on ZK1141 or ZK126 into these strains by selecting for
prototrophy or Smr, and then testing among
those transductants for the cotransduction of the GASP allele, by
assaying directly for the GASP phenotype or another physiological
phenotype where appropriate (see below).
The rpoS+ strains were constructed by using the
cysC95::Tn10Tcr mutation
from CAG12173 and the
rpoS::Kanr
mutation from ZK1000 (4). Strains carrying the
sgaA allele of ZK1141 were constructed with the
lipA150::Tn1000dKanr marker
from strain KER176 (35). Mutants with the sgaA
GASP allele were identified by their larger colony sizes when grown on
M63 glutamate (0.5%) plates (see Results). Strains carrying the
sgaB allele of ZK1141 were constructed with the
serC::mini-MudI194 allele from strain
NU1107 (14). Mutants with the sgaB GASP allele were identified by their increased sensitivity to serine, determined by
a filter disc technique and confirmed by assaying for mucoidy at 30°C
(see Results). Strains carrying the sgaC GASP allele were constructed with the rpsL+ (Sms)
allele of ZK126. Mutants with the sgaC GASP allele were
identified by scoring for the sgaC GASP phenotype (see below).
Stationary-phase competitions.
Competition experiments were
adapted from those of Zambrano et al. (40). For competitions
in LB, initial cultures were inoculated from frozen glycerol stocks
into 3 ml of LB and grown overnight. These were then subcultured 1:100
into fresh LB and incubated for 24 h before being mixed for the
competitions. The two populations were monitored by serial dilution in
M63 medium and plating on minimal salicin and minimal
glucose-plus-valine plates. We verified that the majority of the
population remained prototrophic (and hence detectable on the selection
media) by comparing the counts on the selection media with those on LB.
In no case did we observe a difference in total viable counts on
minimal and rich media. For competitions in M63-serine
(0.5%)-isoleucine (0.03%)-valine (0.03%)-leucine (0.03%)-NaCl
(0.5%), colonies were inoculated from an LB plate into the defined
medium, and the cultures were incubated until they reached stationary
phase (1 to 4 days). Cultures of strain ZK2618
(trpB::Tn10) were also supplemented
with 0.004% tryptophan to facilitate growth. The ZK1141 and ZK2618
cultures were washed in M63 medium before inoculating as a 1:10,000
minority into the ZK820 cultures. The two populations were monitored by serial dilution in M63 medium and plating on LB-streptomycin and LB-nalidixic acid.
Molecular techniques.
The DNA flanking the
mini-Tn10Cmr transposons was determined by using
an arbitrary PCR-based protocol (5), with the modifications described by Pratt and Kolter (28). PCR products were
subjected to sequence analysis by the Micro Core Facility, Department
of Microbiology and Molecular Genetics, Harvard Medical School, and the
sequences were compared with the GenBank DNA database by using the
BLAST program (1).
 |
RESULTS |
Isolation and mapping of three new GASP loci from an aged
rpoS819 strain.
Our approach to investigate the
physiology of the GASP phenomenon was to identify and characterize
several mutations able to confer the GASP phenotype. That many rounds
of GASP takeover occur in starved cultures of E. coli
(7, 40) implies that the survivors have acquired multiple
GASP mutations. As we were interested in exploring potential genetic
interactions of accumulated GASP mutations, our strategy was to isolate
and investigate the GASP mutations of a single mutant survivor (ZK1141)
from a culture that had undergone several rounds of population takeover.
We have devised a nomenclature that describes the relationship of the
GASP mutants within a single lineage (Table
2). Gn (short for
GASPn) denotes an isolate from an aged
culture of strain Gn
1 that
is capable of outcompeting the Gn
1
strain in a stationary-phase competition. In this study we analyzed the
GII strain ZK1141 (rpoS819 sgaA sgaB
sgaC), which is descended from the GI strain ZK819 (rpoS819), which is descended from the
G0 wild-type strain ZK126 (all
Gn designations in this work refer to these
strains).
ZK1141 was isolated as a Smr survivor of a mixed culture; a
10-day-old culture of ZK819 and a 1-day-old culture of the
Sms nalidixic acid-resistant (Nalr) version of
ZK819 (ZK820) were grown together in fresh LB and then incubated for a
week under starvation conditions (37). ZK1141 has the
GII phenotype: it is capable of completely taking over a 1-day-old population of GI when
inoculated as a 1-day-old minority (38).
The mutation responsible for the GI GASP
phenotype of ZK819 has been identified as an allele of rpoS
called rpoS819 (40). The
GII phenotype of ZK1141 was initially thought to
be due to a single mutation, which was termed sga, for
stationary-phase growth advantage (38). However, genetic
analysis of ZK1141 (see below) has demonstrated that there are three
GASP mutations that each contribute to the GII
GASP phenotype.
We identified the mutations responsible for the
GII phenotype of ZK1141 with a genetic selection
technique adapted from Zambrano et al. (40): when introduced
into the GI strain, the
GII GASP alleles conferred a GASP phenotype versus the GI parent. We made a pool of
approximately 1,000 GII mutants with randomly
inserted mini-Tn10Tcr or Kanr
transposons in the chromosome. We then selected for linkage of the
mini-Tn10 to the GASP alleles by making a P1vir
lysate of the pool and infecting GI with this
lysate to obtain a new pool of about 500 Tcr or
Kanr transductants. These pools were then inoculated as a
minority into 1-day-old ZK820 (the Nalr Sms
GI strain) cultures, and the cultures were
allowed to further starve to select from the pool those
GI transductants carrying
GII alleles: these transductants could grow in the starved culture, whereas the GI
transductants not carrying the GII GASP alleles
could not. The GI transductants carrying the
GII GASP alleles were isolated from the culture several days after the pool was inoculated by titering the culture onto
LB-streptomycin Sm plates. We then confirmed that the
mutants isolated on the LB-streptomycin titer plate had the
GII GASP alleles by moving their
mini-Tn10 alleles into a fresh GI background by P1vir transduction and testing among those
transductants for cotransduction of the GII GASP
phenotype by competition versus the Nalr
GI. In this manner, we identified three distinct
mutations harbored by GII that conferred a GASP
phenotype to GI. These mutations were designated
sgaA, sgaB, and sgaC.
Mapping the GII GASP loci.
During our
investigations of strain ZK1141, we discovered that it has two
phenotypes that its ZK819 parent lacks: mucoid growth on glucose at
30°C (but not at 37°C) and an enhanced sensitivity to the amino
acid serine. Serine is a competitive inhibitor of homoserine
dehydrogenase I, and high levels of intracellular serine result in
isoleucine starvation (9, 10). We scored relative serine
sensitivities by streaking the strains on an M63-glucose plate toward a
filter disc soaked with 10% serine placed in the center of the plate
and determining the relative sizes of the growth inhibition zones.
Instrumental in the mapping of the sgaB locus was the
discovery that the sgaB GASP allele is responsible for both
the mucoidy and serine sensitivity phenotypes of ZK1141. The
sgaB mutation was mapped to min 20 by using the Hfr and P1 mapping sets (31); the sgaB mutation was 95%
linked to the
zbj-3110::Tn10Kanr marker
of CAG18528, located at min 19.8 (2, 31).
The sgaA and sgaC mutations were each mapped by
determining the location of random mini-Tn10Cmr
insertions linked to the initial mini-Tn10Tcr or
mini-Tn10Kanr insertions used to isolate the
GASP alleles (see above). These mini-Tn10Cmr
markers were mapped by the arbitrarily primed PCR technique. The
sgaA-linked mini-Tn10Cmr was found to
be in ybdN at min 13.7 and was 60% linked to the mini-Tn10Tcr, which in turn was 10% linked to
sgaA. The sgaC-linked
mini-Tn10Cmr was found to be in gspA
at min 74.4, which was 66% linked to the
mini-Tn10Kanr, which in turn was 50% linked to
sgaA.
The GASP phenotypes of three new GASP loci: sgaA,
sgaB, and sgaC.
Having isolated and mapped three
GASP alleles of strain GII, we wanted to test
whether each of these alleles alone could confer a selective advantage
over the GI parent during stationary phase. We
assayed for the GASP phenotype by mixing 24-h-old cultures of the two
strains in question and monitoring changes in each population by viable
count assay. The two populations were distinguished because they carry
different neutral markers. Marker neutrality was confirmed empirically
by switching the markers between the strains and performing all mixes
reciprocally. Viable counts of each population are determined by
titering the culture on the two relevant selection plates. Previous
reports suggested that the rpsL allele conferring
Smr and the gyrA allele conferring
Nalr are neutral in stationary-phase competitions in
E. coli (7, 40). We confirmed that the
Smr and Nalr markers are neutral during
extended starvation. However, during the first 4 days of competition of
a 1:1 mix (see below), viable counts were consistently 2- to 10-fold
higher for the Smr strain than for the Nalr
strain, although the Smr counts eventually dropped to equal
those of the Nalr population. Since the first 4 days of the
competitions in this study were critical, we differentially marked the
ZK819 (Smr) strain with two new markers that remain neutral
throughout the competition: valine-resistant growth on glucose
(Valr) and the ability to grow on
-glucosides
(Bgl+). The Valr and Bgl+ markers
were isolated as spontaneous mutations conferring the ability to grow
on M63-glucose-valine or M63-salicin plates, respectively. Unless
otherwise noted, this pair of markers was used for all competitions
described below.
The Valr mutation mapped to the ilvGMEDA operon.
Since E. coli K-12 has a frameshift in ilvG,
which prevents expression of the one Valr isozyme of
acetohydroxy acid synthase of E. coli, encoded by ilvGM (16), the Valr mutation is most
likely a suppressor of this frameshift. The Bgl+ mutants
arose at high frequency in our ZK819 and ZK1141 strains (about 1 in
107 plated cells), which prevented transduction of the same
allele into either background. We therefore selected for
Bgl+ mutants in both ZK819 and ZK1141 backgrounds. Both
Bgl+ mutations mapped to the bgl operon and are
likely to be insertions or point mutations in the bglR
regulatory locus (30). The neutrality of the
Valr and Bgl+ mutations throughout the
starvation period was demonstrated by competitions of the
Valr and Bgl+ derivatives of the ZK819 and
ZK1141 strains. Neither marker conferred a competitive advantage or
disadvantage, as determined by 1:1 competitions (Fig.
1). Furthermore, neither strain grew as a
1:1,000 minority versus the other strain (data not shown). Finally,
neither of the two mutations altered the fitness of the strains versus the Vals Bgl
parent (data not shown). Each
mix was performed at least four times.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
The Valr and Bgl+ markers are
selectively neutral in stationary phase. One-day-old cultures of the
Valr (ZK2552) ( ) and Bgl+ (ZK2553) ( )
derivatives of the GI mutant (ZK819) were mixed
1:1 and cocultured. Viable counts were assayed on M63-glucose-valine or
M63-salicin plates. Neither strain was outcompeted in four
competitions.
|
|
The fact that we can isolate mutants with the GASP phenotype from
starved bacterial cultures suggests that these GASP mutants, starting
from a single mutant cell, are able to increase in number during the
starvation period to establish themselves as the majority population.
One assay for the GASP phenotype is thus the ability of the mutant,
when placed as a minority population in a culture of the parent, to
grow relative to the parent and eventually establish itself as the
majority population. To demonstrate this aspect of GASP for each of the
GII GASP alleles, we constructed the
GI sgaA (the GI
strain that has the sgaA allele of
GII), GI sgaB, and
GI sgaC strains with the Valr
or Bgl+ selectable marker and competed them as a 1,000-fold
minority with the GI parent that had the other
selectable marker. Figure 2 demonstrates
that each of the three GASP alleles confers the ability to grow when
inoculated as a minority and take over the population. Like the
GII mutant (Fig. 2A), the GI sgaA mutant grew on the first day of the competition (Fig.
2B), while the GI sgaB and
GI sgaC mutants experienced a 1-day lag
period before growth (Fig. 2C and D). However, none of the
GI mutants with a single
GII GASP allele was able to eliminate the
majority population as rapidly or as completely as the
GII mutant, suggesting that their fitness advantages are additive, a possibility addressed below.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
The GII alleles of ZK1141 confer
the GASP phenotype. Into a 1-day-old culture of the
GI mutant (ZK2552) ( ) was inoculated as a
1,000-fold minority of a 1-day-old culture of the
GII strain (ZK2555) (A), the
GI sgaA strain (ZK2561) (B), the
GI sgaB strain (ZK2559) (C), or the
GI sgaC strain (ZK2563) ( ) (D).
Asterisks indicate that viable counts fell below detectable levels
(<103 CFU/ml). The patterns of GASP takeovers were
identical in six replicate mixtures, including ones where the
selectable markers were switched between competing strains.
|
|
Another component of the GASP phenotype is the ability of the GASP
mutant to directly outcompete the parent, resulting in the death of the
parent. This ability is assayed by mixing the two cultures in a 1:1
ratio and looking for the decline of one of the two populations during
the starvation period. Figure 3 demonstrates that all three of the GI mutants
with a GII GASP allele are capable of
outcompeting the GI parent. Interestingly,
during the first 2 days of the 1:1,000 and 1:1 mixes for both
GII and GI sgaA
mutants (Fig. 2A and B and 3A and B), the GASP mutant could grow as a
minority population but did not yet outcompete the
GI parent when mixed in equal numbers. This
finding implies that while there may be utilizable carbon for the
strains available during the first 2 days, the competition for those
nutrients does not become lethal for the parental strain until the
environmental conditions change as a result of continued starvation.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
The GII alleles confer a
competitive advantage to GI cells. A 1-day-old
culture of the GI mutant (ZK2552) ( ) was
mixed 1:1 with a 1-day-old culture of the GII
strain (ZK2555) (A), the GI sgaA strain
(ZK2561) (B), the GI sgaB strain (ZK2559)
(C), or the GI sgaC strain (ZK2563) ( )
(D). Asterisks indicate that viable counts fell below detectable levels
(<103 CFU/ml). The patterns of GASP takeovers were
identical in six replicate mixtures, including ones where the
selectable markers were switched between the competing strains.
|
|
The three GII GASP mutations are necessary and
sufficient for the GII GASP phenotype.
Our selection
method identified three new distinct GASP loci on the chromosome of
GII: sgaA, sgaB, and
sgaC. To determine whether there are additional GASP
mutations in GII, we examined whether the three
GASP mutations identified so far were both necessary and sufficient for
the GII GASP phenotype. Our first approach was
to compete the GII mutant with a constructed
GI sgaA sgaB sgaC mutant. Neither strain
had a competitive advantage when competed in a 1:1 mix (Fig.
4). Furthermore, the
GII mutant was unable to grow when inoculated as
a 1:1,000 minority into a culture of the GI
sgaA sgaB sgaC (data not shown). These results demonstrate
that the GII strain lacks any additional GASP
mutations that would confer a competitive advantage over the
constructed strain. Additionally, the GI sgaA
sgaB sgaC strain grew immediately and completely displaced the
GI strain as the majority when inoculated as a
1:1,000 minority into the GI culture (data not
shown); this GASP phenotype was indistinguishable from that of the
GII strain (Fig. 2A). The results from these
three different competition experiments thus demonstrate that the
sgaA, sgaB, and sgaC mutations are
sufficient for the GII GASP phenotype.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
The sgaA, sgaB, and
sgaC alleles are sufficient for the
GII GASP phenotype of ZK1141. A 1-day-old
culture of the reconstructed GII strain
GI sgaA sgaB sgaC (ZK2564) ( ) was mixed
1:1 with a 1-day-old culture of the GII strain
(ZK2554) ( ). Neither strain was outcompeted in eight competitions.
|
|
We next asked if all three GII GASP alleles were
necessary for the GII GASP phenotype. We
competed 1:1 the GII strain versus one of three
constructed strains harboring two of the three
GII GASP mutations: GI
sgaA, sgaB, GI sgaA
sgaC, or GI sgaB sgaC. In every case,
the GII strain outcompeted the constructed
strain (data not shown). Hence, all three reconstructed strains, each
lacking one of the three GII alleles, were less
fit than GII, indicating that each of the three
GII alleles is necessary for the full fitness
gain of the GII strain. That each is necessary for the GII GASP phenotype indicates that they
act additively to confer higher and higher fitnesses in stationary phase.
GASP mutants obtain nutrients from dying cells in a chemically
defined medium.
Because growth in LB ceases due to carbon
limitation (37), it has been assumed that the GASP mutants
obtain the nutrients required for growth from the dying majority
population. To demonstrate directly that the dying cells release
nutrients which the GASP mutants can utilize during growth, we
identified a chemically defined medium in which the
GII GASP strain could grow and outcompete the
GI strain. Figure
5A shows the GASP phenotype of the
GII strain versus GI
after both cultures were grown to stationary phase in M63 salts medium
supplemented with serine (0.5%), isoleucine, valine, and leucine
(0.03% each), and NaCl (0.5%). As in LB, the
GII strain grew rapidly as a 1:10,000 minority
to take over the population. Like the prototroph, a tryptophan
auxotrophic derivative of the GII strain
(trpB::Tn10) was able to grow and take
over the GI minority (Fig. 5B). This finding
indicates that the GII strain can scavenge enough tryptophan to meet its growth requirement during the population takeover. As no exogenous tryptophan was supplied by the medium, the
only remaining source of tryptophan is the cells of the dying majority
population. This is the first evidence that the GASP mutants can
scavenge nutrients released by the dying cells during carbon
starvation.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
GASP in a chemically defined medium. Stationary-phase
cultures grown in M63-serine (0.5%)-isoleucine (0.03%)-valine
(0.03%)-leucine (0.03%)-NaCl (0.5%) (plus tryptophan [0.004%] for
the GII trpB::Tn10
strain [ZK2618]) were mixed 1:10,000 to assay the GASP phenotype.
Both the GII strain (ZK1141; ) (A) and the
tryptophan auxotrophic GII trpB::Tn10 strain (ZK2618; ) (B)
express the GASP phenotype as a minority versus the
GI strain (ZK820; ). The patterns of GASP
takeovers were identical in four competitions.
|
|
The three GII GASP alleles and the rpoS819
allele confer faster growth on amino acids.
We reasoned that the
primary selective force acting on carbon-starved cells is the ability
to utilize the carbon released by the dying majority population.
Therefore, we asked whether the GASP mutations confer faster growth on
carbon sources that may resemble the nutrients released by dying cells.
The three GII GASP mutations were tested in the
GI background, as it was from this background
that GII was selected. We also tested the growth
phenotypes of the GI GASP mutation, rpoS819, by comparing its growth rate with that of the
GI strain carrying the
rpoS+ allele (this is essentially a
G0 strain, as the rpoS819 mutation is
sufficient to confer the GI GASP phenotype of
ZK819 [38]). We first assayed growth on LB, a rich
medium containing many of the building blocks, vitamins, and energy
sources necessary for growth. The growth rates on LB were
indistinguishable between the different mutant strains (data not shown).
The composition of the medium during prolonged carbon starvation has
not been characterized. However, we speculated that amino acids are the
most abundant nutrients released by the dying cells, given that amino
acids account for most of the dry weight of E. coli
(26). Hence, we determined the relative growth rates of the
GASP mutants on mixtures of amino acids, either as a combination of
monomers and short peptides (tryptone) or only as monomers (Casamino
Acids). While none of the individual GASP alleles had much of an
effect, the GII strain harboring all three
GII GASP mutations grew significantly faster
than GI on the monomer and peptide mixture
(Table 3). In contrast, all four GASP
mutations conferred significantly faster growth on the mixture of the
amino acid monomers. Interestingly, in every case, the strains with
more GASP mutations grew faster, indicating that the GASP mutations act
additively to confer faster growth on mixtures of amino acids.
Since all four GASP mutations confer faster growth on mixtures of amino
acids, we attempted to identify individual amino acids that the GASP
mutants could catabolize more rapidly. We assayed growth in liquid
media containing M63 salts and the amino acid in question at 0.5%
(wt/vol). Because of the potential problem of amino acids such as
serine and cysteine inhibiting isoleucine biosynthesis and thus
preventing growth on single amino acids (9, 10), we
supplemented all of the growth media with isoleucine (0.03%). We
assayed for the ability of the GASP mutants to grow on each of the 20 amino acids singly as the sole source of carbon and energy. At least
one of the six strains tested could grow on alanine, asparagine,
aspartate, glutamate, glutamine, proline, serine, or threonine; none
grew on the other 11 amino acids. While E. coli K-12 can
grow on tryptophan (32), our strains were not expected to
grow, as they lack tryptophanase activity due to the tna2 mutation.
All four GASP alleles conferred growth advantages on several amino
acids, manifested as a higher growth rate or, in some cases, a new
ability to grow on the particular amino acid (Table
4). The rpoS819 GASP allele
conferred upon the cell the new ability to utilize asparagine and
glutamine as sole sources of carbon and energy. However, the
rpoS819 mutants grew to an OD at 600 nm of only about 0.3 on
glutamine. It is therefore uncertain whether the cells grew
incompletely on glutamine or grew on an impurity in the glutamine
supply instead. The rpoS819 allele alone conferred faster
growth on glutamate, serine, threonine, and alanine. The sgaA allele conferred the new ability to grow on aspartate
and conferred faster growth on asparagine and glutamate. The
sgaB and sgaC alleles both conferred faster
growth on alanine, threonine, and serine. Comparison of the growth
rates for the G0, GI, and
GII strains indicates that both the repertoire of amino acids and the growth rates on the amino acids increase as more
GASP alleles are added and demonstrates that these GASP alleles act
additively to increase the overall capacity to catabolize amino acids.
We were not able to obtain relative growth rates on proline in liquid
cultures, because the cultures were consistently taken over by
faster-growing mutants. However, we were able to obtain estimates of
relative growth rates by comparing the sizes (surface area) of colonies
grown on M63-proline (plus isoleucine) plates (Table 4). The
sgaA and sgaC alleles conferred faster growth on
proline, and their effects on growth were strikingly additive, as the
GII colonies were significantly larger than
those of the GI mutants with either single
allele alone.
Interestingly, the four GASP alleles conferred slower growth on several
of the amino acids (Table 4). The rpoS819 mutation conferred
slower growth on proline; the sgaA mutation conferred slower
growth on alanine, glutamine, and serine; the sgaB mutation conferred slower growth on asparagine, glutamate, glutamine, and proline; and the sgaC mutation conferred slower growth on
asparagine, glutamate, and glutamine. This indicates that while the
individual GASP alleles confer fitness gains on some amino acids, each
also confers a fitness loss on other amino acids. We discuss the
implications of these observations below.
 |
DISCUSSION |
Previous work identified an allele of rpoS,
rpoS819, as a mutation that can confer the GASP phenotype on
E. coli (40). Genetic analysis of an isolate
(GII) from a starved culture of the
rpoS819 GASP strain (GI) has revealed
three new GASP mutations: sgaA, sgaB, and
sgaC. All four GASP mutations of this isolate map to
different regions of the chromosome, suggesting that there are many
loci that when mutated can confer fitness advantages in stationary phase.
As each of the three new GASP mutations acquired by the
GII strain can confer a GASP phenotype on the
GI parental strain, it is most likely that they
were acquired as a result of three successive GASP takeover events.
GII was isolated from a culture starved for a
total of about 2.5 weeks, which suggests that in our experimental
system population takeovers during starvation can happen faster than
once per week. The fact that the three GII GASP
mutations are necessary (and sufficient) for the GII GASP phenotype demonstrates directly that
the acquisition of multiple GASP mutations can provide successively
higher fitnesses for starved bacteria. The continual accumulation of
GASP mutations by cells within the surviving population can account for
the multiple rounds of population takeovers observed in starved
cultures (7, 40). Our results thus support the growing body
of evidence that starved populations are highly dynamic and undergo
frequent population takeovers as a result of fitness differences among
the competing subpopulations (7, 8, 40).
A major purpose of our investigation was to understand how GASP
mutations alter cell physiology to provide fitness gains in stationary
phase. Previous studies have demonstrated that fitness gains during
conditions of limited substrate availability in chemostats or
selections for growth on novel substrates were manifested as increases
in catabolic potential for those substrates (11, 17, 20, 24, 33,
36). In our system, we have observed that dying cells in
stationary-phase cultures release nutrients (e.g., tryptophan) that can
be utilized by the growing GASP mutants, and we hypothesized that the
GASP mutants selected are those that outcompete their parents for these
limited substrates. We observed a direct correlation between relative
GASP fitness and relative ability to catabolize amino acids, which are
likely to be the most abundant nutrients released by dying cells
(26). The GI GASP mutation
rpoS819 and the three GII GASP
mutations sgaA, sgaB, and sgaC all
confer higher growth rates on an amino acid mixture (Casamino Acids).
To our knowledge, this is the first report that mutations in
rpoS can alter amino acid catabolism during exponential
growth, extending previous observations that wild-type
S
affects the physiology of both arrested and growing cells (12, 27).
All four of the GASP mutations examined in this study also increase the
ability of the cell to utilize certain amino acids singly as the sole
source of carbon and energy. These changes were manifested as either a
higher growth rate or a new ability to grow on the particular amino
acid. The GASP mutations are pleiotropic in this respect, as each
affects growth on several amino acids. The subsets of amino acids on
which they confer a growth advantage are overlapping but distinct. In
general, these subsets contain amino acids that enter catabolism along
the same major degradative pathways (reviewed in reference
18) (Fig. 6). The
sgaA allele confers a growth advantage on amino acids that
enter the central metabolic pathway through aspartate and fumarate,
while the sgaB and sgaC alleles confer growth
advantages on amino acids that enter this pathway through pyruvate (the
effect of sgaC on proline metabolism is the one exception).
The rpoS819 mutation, on the other hand, affected both of
these degradative pathways. It is tempting to speculate that the GASP
mutations, especially rpoS819, alter the regulation of the
enzymes of these degradative pathways. We are currently investigating
the mechanistic bases of these physiological changes.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 6.
The primary catabolic pathways for the amino acids on
which the GASP mutants have a growth advantage (reviewed by McFall and
Newman [18]). The arrows indicate enzymatic steps
between metabolites. Boxed amino acids denote amino acids that can
serve as sole sources of carbon and energy for at least one of the six
strains tested. Listed under the boxed amino acids are the loci whose
GASP alleles confer a growth advantage on the amino acid. An asterisk
indicates the GASP allele that confers the novel ability to grow on the
amino acid.
|
|
Based on our findings, we propose a model for a physiological basis of
GASP (Fig. 7). We hypothesize that the
primary selective force acting on carbon-starved cells is the ability
to scavenge carbon sources released by the dying cells for the purposes
of cell maintenance and growth. Cells unable to obtain a sufficient supply of carbon and energy can no longer maintain activities essential
for viability, and they die. The fact that in every case studied the
GASP fitness correlates directly with the capacity to catabolize amino
acids leads us to propose that the most significant nutrients released
are catabolizable amino acids. At the onset of starvation, the
population is composed almost entirely of cells of the parental
genotype that compete with equal fitness for carbon sources. Hence, the
death during the first few days of starvation is stochastic, as all
parental cells have an equal chance of scavenging the nutrients and
surviving. However, the rare mutants within the population expressing
the GASP phenotype outcompete their parents for the carbon resources
because of their enhanced catabolic capabilities. These advantages
provide the GASP cells with enough resources not only to survive but to
grow and divide during starvation conditions. Once the GASP mutants
grow to a significant cell density, they effectively decrease the
amount of carbon available to the parental cells. These parental cells
die as a result and release their nutrients into the medium. This model
involves two positive feedback loops which can account for both the
rapid growth of the GASP mutant and the rapid death of the parent.
Supporting our model is the finding that if the
GII strain ZK1141 lacks the respiratory enzyme
NADH dehydrogenase I, essential for the utilization of several amino
acids catabolized by GII (29), it
loses the GASP phenotype versus the GI parental strain, ZK819 (38).
Interestingly, we observed that while GI mutants
with a single GII allele grow faster than
GI with certain amino acids as sole carbon
sources, they grow slower with others. This result may seem
inconsistent with our model for the physiological basis of GASP.
However, growth on mixed amino acids may more accurately reflect the
growth of the GASP mutants during starvation, since all amino acids are
likely to be released at similar rates from the dying cells. We have
demonstrated that all four GASP alleles confer an overall advantage
when growing on mixed amino acids (Casamino Acids). Hence, our results
suggest that when the GASP mutants are competing with their parents for
the complex mixtures of nutrients released by the dying cells, their
faster growth on some amino acids outweighs their slower growth on others.
We thank J. E. Cronan, Jr., M. E. Winkler, and A. Wright for providing strains. We thank S. E. Finkel, G. A. O'Toole, and L. A. Pratt for critical reading of the manuscript
and members of the Kolter lab for helpful comments.
This work was supported by grants from the National Science
Foundation (MCB9728936) and the National Institutes of Health (GM55199).
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[Medline].
|
| 2.
|
Berlyn, M. K.,
K. B. Low, and K. E. Rudd.
1996.
Linkage map of Escherichia coli K-12, edition 9, p. 1715-1902.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typhimurium: cellular and molecular biology. ASM Press, Washington, D.C.
|
| 3.
|
Blackburn, N.,
T. Fenchel, and J. Mitchell.
1998.
Microscale nutrient patches in planktonic habitats shown by chemotactic bacteria.
Science
282:2254-2256[Abstract/Free Full Text].
|
| 4.
|
Bohannon, D. E.,
N. Connell,
J. Keener,
A. Tormo,
M. Espinosa-Urgel,
M. M. Zambrano, and R. Kolter.
1991.
Stationary-phase-inducible "gearbox" promoters: differential effects of katF mutations and the role of 70.
J. Bacteriol.
173:4482-4492[Abstract/Free Full Text].
|
| 5.
|
Caetano-Annoles, G.
1993.
Amplifying DNA with arbitrary oligonucleotide primers.
PCR Methods Appl.
3:85-92[Medline].
|
| 6.
|
Connell, N.,
Z. Han,
F. Moreno, and R. Kolter.
1987.
An E. coli promoter induced by the cessation of growth.
Mol. Microbiol.
1:195-201[Medline].
|
| 7.
|
Finkel, S. E., and R. Kolter.
1999.
Evolution of microbial diversity during prolonged starvation.
Proc. Natl. Acad. Sci. USA
96:4023-4027[Abstract/Free Full Text].
|
| 8.
|
Finkel, S. E.,
E. Zinser,
S. Gupta, and R. Kolter.
1997.
Life and death in stationary phase.
Mol. Microbiol.
103:3-16.
|
| 9.
|
Hama, H.,
T. Kayahara,
M. Tsuda, and T. Tsuchiya.
1991.
Inhibition of homoserine dehydrogenase I by L-serine in Escherichia coli.
J. Biochem.
109:604-608[Abstract/Free Full Text].
|
| 10.
|
Hama, H.,
Y. Sumita,
Y. Kakutani,
M. Tsuda, and T. Tsuchiya.
1990.
Target of serine inhibition in Escherichia coli.
Biochem. Biophys. Res. Commun.
168:1211-1216[Medline].
|
| 11.
|
Helling, R. B.,
C. N. Vargas, and J. Adams.
1987.
Evolution of Escherichia coli during growth in a constant environment.
Genetics
116:349-358[Abstract/Free Full Text].
|
| 12.
|
Hengge-Aronis, R.
1996.
Regulation of gene expression during entry into stationary phase, p. 1497-1512.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C.
|
| 13.
|
Kleckner, N.,
J. Bender, and S. Gottesman.
1991.
Uses of transposons with emphasis on Tn10.
Methods Enzymol.
204:139-180[Medline].
|
| 14.
|
Lam, H. M., and M. E. Winkler.
1990.
Metabolic relationships between pyridoxine (vitamin B6) and serine biosynthesis in Escherichia coli.
J. Bacteriol.
172:6518-6528[Abstract/Free Full Text].
|
| 15.
|
Lange, R., and R. Hengge-Aronis.
1991.
Growth phase-regulated expression of bolA and morphology of Escherichia coli cells is controlled by the novel sigma factor, S (rpoS).
J. Bacteriol.
173:4474-4481[Abstract/Free Full Text].
|
| 16.
|
Lawther, R. P.,
D. H. Calhoun,
C. W. Adams,
C. A. Hauser,
J. Gray, and G. W. Hatfield.
1981.
Molecular basis of valine resistance in Escherichia coli K-12.
Proc. Natl. Acad. Sci. USA
78:922-925[Abstract/Free Full Text].
|
| 17.
|
Lenski, R. E.,
J. A. Mongold,
P. D. Sniegowski,
M. Travisano,
F. Vasi,
P. J. Gerrish, and T. M. Schmidt.
1998.
Evolution of competitive fitness in experimental populations of E. coli: what makes one genotype a better competitor than another?
Antonie Leeuwenhoek
73:35-47[Medline].
|
| 18.
|
McFall, E., and E. B. Newman.
1996.
Amino acids as carbon sources, p. 358-379.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C.
|
| 19.
|
Miller, J. H.
1992.
A short course in bacterial genetics.
Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
|
| 20.
|
Miller, R. D.,
D. E. Dykhuizen,
L. Green, and D. L. Hartl.
1984.
Specific deletion occurring in the directed evolution of 6-phosphogluconate dehydrogenase in Escherichia coli.
Genetics
108:765-772[Abstract/Free Full Text].
|
| 21.
|
Moriarty, D. J. W., and R. T. Bell.
1993.
Bacterial growth and starvation in aquatic environments, p. 25-53.
In
S. J. Kjelleberg (ed.), Starvation in bacteria. Plenum Press, New York, N.Y.
|
| 22.
|
Morita, R. Y.
1988.
Bioavailability of energy and its relationship to growth and starvation survival in nature.
Can. J. Microbiol.
34:436-441.
|
| 23.
|
Morita, R. Y.
1993.
Bioavailability of energy and the starvation state, p. 1-23.
In
S. Kjelleberg (ed.), Starvation in bacteria. Plenum Press, New York, N.Y.
|
| 24.
|
Mortlock, R. P.
1982.
Metabolic acquisitions through laboratory selection.
Annu. Rev. Microbiol.
36:259-284[Medline].
|
| 25.
|
Mulvey, M. R.,
P. A. Sorby,
B. L. Triggs-Raine, and P. C. Loewen.
1988.
Cloning and physical characterization of katE and katF required for catalase HPII expression in Escherichia coli.
Gene
73:337-345[Medline].
|
| 26.
|
Neidhardt, F. C., and H. E. Umbarger.
1996.
Chemical composition of Escherichia coli, p. 13-28.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C.
|
| 27.
|
Notley, L., and T. Ferenci.
1996.
Induction of RpoS-dependent functions in glucose-limited continuous culture: what level of nutrient limitation induces the stationary phase of Escherichia coli?
J. Bacteriol.
178:1465-1468[Abstract/Free Full Text].
|
| 28.
|
Pratt, L. A., and R. Kolter.
1998.
Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili.
Mol. Microbiol.
30:285-293[Medline].
|
| 29.
|
Prüß, B. M.,
J. M. Nelms,
C. Park, and A. J. Wolfe.
1994.
Mutations in NADH:ubiquinone oxidoreductase of Escherichia coli affect growth on mixed amino acids.
J. Bacteriol.
176:2143-2150[Abstract/Free Full Text].
|
| 30.
|
Reynolds, A. E.,
J. Felton, and A. Wright.
1981.
Insertion of DNA activates the cryptic bgl operon of E. coli.
Nature
293:625-629[Medline].
|
| 31.
|
Singer, M.,
T. A. Baker,
G. Schnitzler,
S. M. Deischel,
M. Goel,
W. Dove,
K. J. Jaacks,
A. D. Grossman,
J. W. Erickson, and C. A. Gross.
1989.
A collection of strains containing genetically linked alternating antibiotic resistance elements for genetic mapping of Escherichia coli.
Microbiol. Rev.
53:1-24[Abstract/Free Full Text].
|
| 32.
|
Snell, E. E.
1975.
Tryptophanase: structure, catalytic activities and mechanisms of action.
Adv. Enzymol.
42:287-333.
|
| 33.
|
Sonti, R. V., and J. R. Roth.
1989.
Role of gene duplications in the adaptation of Salmonella typhimurium to growth on limiting carbon sources.
Genetics
123:19-28[Abstract/Free Full Text].
|
| 34.
|
Taylor, B. L.
1983.
How do bacteria find the optimal concentration of oxygen?
Trends Biochem. Sci.
8:438-441.
|
| 35.
|
Vanden Boom, T. J.,
K. E. Reed, and J. E. Cronan, Jr.
1991.
Lipoic acid metabolism in Escherichia coli: isolation of null mutants defective in lipoic acid biosynthesis, molecular cloning and characterization of the E. coli lip locus, and identification of the lipoylated protein of the glycine cleavage system.
J. Bacteriol.
173:6411-6420[Abstract/Free Full Text].
|
| 36.
|
Weikert, C.,
U. Sauer, and J. E. Bailey.
1997.
Use of a glycerol-limited, long-term chemostat for isolation of Escherichia coli mutants with improved physiological properties.
Microbiology
143:1567-1574[Abstract].
|
| 37.
|
Zambrano, M. M.
1993.
Ph.D. thesis.
Harvard University, Cambridge, Mass.
|
| 38.
|
Zambrano, M. M., and R. Kolter.
1993.
Escherichia coli mutants lacking NADH dehydrogenase-I have a competitive disadvantage in stationary phase.
J. Bacteriol.
175:5642-5647[Abstract/Free Full Text].
|
| 39.
|
Zambrano, M. M., and R. Kolter.
1996.
GASPing for life in stationary phase.
Cell
86:181-184[Medline].
|
| 40.
|
Zambrano, M. M.,
D. A. Siegele,
M. Almirón,
A. Tormo, and R. Kolter.
1993.
Microbial competition: Escherichia coli mutants that take over stationary phase cultures.
Science
259:1757-1760[Abstract/Free Full Text].
|